Evidence map›Paper›PMID 34275087›Full record

ReviewMolecular neurobiology2021

Mitochondrial Quality Control in Cerebral Ischemia-Reperfusion Injury.

Mimi Wu, Xiaoping Gu, Zhengliang Ma

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Molecular neurobiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04998357 (Study Title), which is not on this map. Cited by 59 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 1 pooled it
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04998357 narecruitingnot on this map

Study Title: Autologous Mitochondrial Transplant for Cerebral Ischemia

TypeinterventionalSponsorUniversity of WashingtonRan2021 to 2026Enrolled20ConditionsCerebral IschemiaArmsEndovascular autologous mitochondrial transplantation
3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 1 synthesis or guideline pooled it, 100 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Mimi WuDepartment of Anesthesiology, Affiliated Drum Tower Hospital of Medical Department of Nanjing University, Nanjing, People's Republic of China.
Xiaoping GuDepartment of Anesthesiology, Affiliated Drum Tower Hospital of Medical Department of Nanjing University, Nanjing, People's Republic of China.
Zhengliang MaDepartment of Anesthesiology, Affiliated Drum Tower Hospital of Medical Department of Nanjing University, Nanjing, People's Republic of China. mazhengliang1964@nju.edu.cn.ORCID http://orcid.org/0000-0001-6915-2860
Nanjing Drum Tower Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ischemic stroke is one of the leading causes of death and also a major cause of adult disability worldwide. Revascularization via reperfusion therapy is currently a standard clinical procedure for patients with ischemic stroke. Although the restoration of blood flow (reperfusion) is critical for the salvage of ischemic tissue, reperfusion can also, paradoxically, exacerbate neuronal damage through a series of cellular alterations. Among the various theories postulated for ischemia/reperfusion (I/R) injury, including the burst generation of reactive oxygen species (ROS), activation of autophagy, and release of apoptotic factors, mitochondrial dysfunction has been proposed to play an essential role in mediating these pathophysiological processes. Therefore, strict regulation of the quality and quantity of mitochondria via mitochondrial quality control is of great importance to avoid the pathological effects of impaired mitochondria on neurons. Furthermore, timely elimination of dysfunctional mitochondria via mitophagy is also crucial to maintain a healthy mitochondrial network, whereas intensive or excessive mitophagy could exacerbate cerebral I/R injury. This review will provide a comprehensive overview of the effect of mitochondrial quality control on cerebral I/R injury and introduce recent advances in the understanding of the possible signaling pathways of mitophagy and potential factors responsible for the double-edged roles of mitophagy in the pathological processes of cerebral I/R injury.

Indexed as

AnimalsAntioxidantsBrain IschemiaHumansIschemic StrokeMitochondriaMitochondrial DynamicsMitophagyNicorandilReperfusion InjuryVasodilator AgentsAntioxidantsNicorandilVasodilator AgentsCerebral ischemiaMitochondrialMitochondrial quality controlMitophagyReperfusion

Identifiers

PMID34275087
OpenAlexW3185755861

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.